HIPRA Biotech Services enables clients to access HIPRA's extensive experience working with more than 300 biological entities and a diversity of complex biologics manufacturing platforms including: mammalian, avian, and insect cell culture lines for recombinant proteins, peptides, monoclonal antibodies and viral antigens; microbial culture with E. coli and yeast protein expression systems for peptides and recombinant proteins; and formulation and fill & finish of sterile drug products and finished goods. 

Our scientific and technical excellence and the close proximity of our R&D, Manufacturing and Quality teams ensure agility, flexibility and seamless integration across all stages of the life cycle.

With our rapid development approach and large-scale biologics production capacity and flexibility, as demonstrated by HIPRA's record-time development of a COVID-19 vaccine, we significantly enhance and accelerate the timely and reliable development, scale up and commercial supply of your biologic product. 

HIPRA Biotech Services facilities are strategically located in the Western European Union, enhancing the EU’s strategic autonomy and ensuring your product is made in compliance with a stable regulatory environment.  

Facilities are in close proximity between them, ensuring seamless integration between life cycle stages, close to major communication hubs and in a geographic area entirely free from extreme environmental and natural phenomena.

Our state-of-the-art facilities are designed across our deep know-how of biotech processes, following best practices in production flow layouts and segregation, and we only install top-of-the-line equipment from the highest reputation OEMs. 

Throughout our decades of experience manufacturing and releasing biologics, we have demonstrated an unwavering commitment to quality and regulatory compliance, as demonstrated by our inspection results and feedback from inspectorates, suppliers and customers.  

Our facilities are EU GMP certified and leverage advanced technology, streamlined processes and rigorous pharmaceutical industry quality management systems to ensure that each lot meets the highest standards of quality. 

Our CDMO pharma team is comprised of highly skilled professionals who bring a wealth of experience in their respective areas.  

They combine their expertise with an unlimited optimism, passion and “can-do” attitude to make your project their own, adhering to the highest standards, proactively providing each partner with customized support, significantly accelerating your project timelines and enhancing its probabilities of success.